Company Encyclopedia
View More
name
Wtree High Dvd
DHS.US
News
View More

Orion Porfolio Solutions LLC Acquires 18,387 Shares of Exxon Mobil Corporation $XOM

Orion Portfolio Solutions LLC increased its holdings in Exxon Mobil Corporation by 6.4% in Q2, purchasing an additional 18,387 shares, totaling 305,097 shares valued at $32,889,000. Other institutional investors also adjusted their positions in Exxon Mobil. Analysts have mixed ratings on Exxon Mobil, with an average rating of 'Moderate Buy' and a target price of $129.24. Exxon Mobil's stock opened at $118.77, with a market cap of $500.88 billion.

Market Beat·
US
XOM
-0.60%
Market Beat·
US
XOM
-0.60%

This Bristol-Myers Squibb Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday

Top Wall Street analysts upgraded several stocks. B of A Securities' Tim Anderson upgraded Bristol-Myers Squibb (NYSE:BMY) from Neutral to Buy, raising the price target to $61. BTIG's Gregory Lewis upgraded EnerSys (NYSE:ENS) to Buy with a $175 price target. Keybanc's Jackson Ader upgraded Zoominfo Technologies (NASDAQ:GTM) to Sector Weight, Asana Inc (NYSE:ASAN) to Overweight with an $18 price target, and Akamai Technologies (NASDAQ:AKAM) to Overweight with a $115 price target.

benzinga_article·
US
BMY
+2.36%
US
ENS
-2.41%
US
ASAN
-2.45%
benzinga_article·
US
BMY
+2.36%
US
ENS
-2.41%
US
ASAN
-2.45%

AT&T Keeps Quarterly Dividend at $0.2775 a Share, Payable Feb. 2, 2026 to Stockholders of Record on Jan. 12

AT&T Keeps Quarterly Dividend at $0.2775 a Share, Payable Feb. 2, 2026 to Stockholders of Record on Jan. 12

marketscreener·
US
T
+1.15%
marketscreener·
US
T
+1.15%

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields

Wall Street's top analysts provide insights on three high-dividend healthcare stocks. Perrigo (PRGO) has mixed Q3 results and lowered FY25 EPS guidance. Analysts have mixed ratings with price targets cut to $20. Bristol-Myers Squibb (BMY) received FDA Priority Review for a new treatment, with mixed analyst ratings and price targets between $36 and $62. CVS Health (CVS) raised FY2025 EPS and sales guidance, with analysts maintaining Buy ratings and slightly increasing price targets.

benzinga_article·
US
CVS
-1.74%
US
BMY
+2.36%
US
PRGO
-2.16%
benzinga_article·
US
CVS
-1.74%
US
BMY
+2.36%
US
PRGO
-2.16%

B. Riley Wealth Advisors Inc. Buys New Stake in Philip Morris International Inc. $PM

B. Riley Wealth Advisors Inc. acquired a new stake in Philip Morris International Inc. during the 2nd quarter, purchasing 10,479 shares valued at approximately $1.9 million. Other institutional investors also increased their positions in the company. Analysts have given the stock a consensus rating of 'Moderate Buy' with an average target price of $189.00. Philip Morris International recently declared a quarterly dividend of $1.47 per share, yielding 3.8%.

Market Beat·
US
RILY
-0.75%
US
PM
+1.79%
Market Beat·
US
RILY
-0.75%
US
PM
+1.79%
© 2025 Longbridge｜Disclaimer